Bioresponsive Diagnostik - die Zunge als Detektor oraler Entzündungen


The presented diagnostic - a protease cleavable sensor is administered in a chewing gum. Once it comes in contact with patient’s saliva, containing inflammation enzymes, a taste sensation is produced. The patient tastes the presence of inflammation and can tell his doctor about it. The presented diagnostic system can be applied without any power supply anywhere by anybody, at any time - a new dimension of rapid diagnostics.

This is a preview of subscription content, log in to check access.


  1. [1]

    Amar S, Smith L, Fields GB (2017) Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta 1864:1940–1951

    CAS  Article  PubMed  Google Scholar 

  2. [2]

    Jiang T, Olson ES, Nguyen QT et al. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 101:17867–17872

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. [3]

    Gabriel D, Zuluaga MF, van den Bergh H et al. (2011) It is all about proteases: from drug delivery to in vivo imaging and photomedicine. Curr Med Chem 18:1785–1805

    CAS  Article  PubMed  Google Scholar 

  4. [4]

    Uebersax L, Merkle HP, Meinel L (2009) Biopolymerbased growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev 15:263–289

    CAS  Article  PubMed  Google Scholar 

  5. [5]

    Braun AC, Gutmann M, Ebert R et al. (2017) Matrix metalloproteinase responsive delivery of myostatin inhibitors. Pharm Res 34:58–72

    CAS  Article  PubMed  Google Scholar 

  6. [6]

    Ritzer J, Lühmann T, Rode C et al. (2017) Diagnosing periimplant disease targeting the tongue as 24/7 detector. Nat Commun 8:264

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. [7]

    Mombelli A, Lang NP (1998) The diagnosis and treatment of peri-implantitis. Periodontol 2000 17:63–76

    CAS  Article  PubMed  Google Scholar 

  8. [8]

    U. S. Consumer Product Safety Commision (CPSC) (1992) Final Report Study of Aversive Agents.

    Google Scholar 

  9. [9]

    Glendinning JI (1994) Is the bitter rejection response always adaptive? Physiol Behav 56:1217–1227

    CAS  Article  PubMed  Google Scholar 

  10. [10]

    Sorsa T, Tjaderhane L, Salo T (2004) Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10:311–318

    CAS  Article  PubMed  Google Scholar 

  11. [11]

    Laarman AJ, Ruyken M, Malone CL et al. (2011) Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 186:6445–6453

    CAS  Article  PubMed  Google Scholar 

  12. [12]

    Chakraborti S, Chakraborti T, Dhalla NS (2017) Proteases in Human Diseases. Springer, New York

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Lorenz Meinel.

Additional information

Jennifer Ritzer 20012006 Biochemiestudium an der Universität Leipzig, 2013 Promotion (Dr. rer. nat.) in Biologie ebenda. Seit 2013 Postdoc am Institut für Pharmazie und Lebensmittelchemie, Universität Würzburg.

Tobias Miesler Jahrgang 1990. 20102015 Pharmaziestudium an der FU Berlin. Seit 2015 Promotionsstudium an der Universität Würzburg.

Lorenz Meinel Pharmaziestudium an der Universität Würzburg; Promotion (Dr. sc. nat.) in Pharmazeutischer Technologie an der ETH Zürich, Schweiz, und weitere Promotion (Dr. rer. med.) an der Universität Frankfurt a. M.; 2007 Habilitation für das Fachgebiet Pharmazeutische Technologie an der ETH Zürich. 20052010 Direktor bei Novartis Pharmaceuticals, Basel, Schweiz. Seit 2010 Leiter des Lehrstuhls für Pharmazeutische Technologie und Biopharmazie der Universität Würzburg.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ritzer, J., Miesler, T. & Meinel, L. Bioresponsive Diagnostik - die Zunge als Detektor oraler Entzündungen. Biospektrum 23, 782–784 (2017).

Download citation